255 related articles for article (PubMed ID: 17549457)
21. An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
Knoester M; de Boer MG; Maarleveld JJ; Claas EC; Bernards AT; de Jonge E; van Dissel JT; Veldkamp KE
Clin Microbiol Infect; 2014 Apr; 20(4):O207-15. PubMed ID: 24707852
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.
Le Minh V; Thi Khanh Nhu N; Vinh Phat V; Thompson C; Huong Lan NP; Thieu Nga TV; Thanh Tam PT; Tuyen HT; Hoang Nhu TD; Van Hao N; Thi Loan H; Minh Yen L; Parry CM; Trung Nghia HD; Campbell JI; Hien TT; Thwaites L; Thwaites G; Van Vinh Chau N; Baker S
J Med Microbiol; 2015 Oct; 64(10):1162-1169. PubMed ID: 26297024
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
[TBL] [Abstract][Full Text] [Related]
24. Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Soubirou JF; Gault N; Alfaiate T; Lolom I; Tubach F; Andremont A; Lucet JC; Wolff M; Barbier F
Scand J Infect Dis; 2014 Mar; 46(3):215-20. PubMed ID: 24447250
[TBL] [Abstract][Full Text] [Related]
25. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
26. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.
Rios FG; Luna CM; Maskin B; Saenz Valiente A; Lloria M; Gando S; Sosa C; Baquero S; Llerena C; Petrati C; Apezteguia C
Eur Respir J; 2007 Aug; 30(2):307-13. PubMed ID: 17504791
[TBL] [Abstract][Full Text] [Related]
27. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
29. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Kaminski C; Timsit JF; Dubois Y; Zahar JR; Garrouste-Orgeas M; Vesin A; Azoulay E; Feger C; Dumenil AS; Adrie C; Cohen Y; Allaouchiche B;
Crit Care; 2011; 15(2):R112. PubMed ID: 21481266
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of carbapenem-resistant Pseudomonas aeruginosa strains in patients with ventilator-associated pneumonia in intensive care units.
Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Bakšytė G; Macas A; Sakalauskas R
Medicina (Kaunas); 2011; 47(12):652-6. PubMed ID: 22370463
[TBL] [Abstract][Full Text] [Related]
32. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
[TBL] [Abstract][Full Text] [Related]
33. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
[TBL] [Abstract][Full Text] [Related]
34. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
35. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
Tsioutis C; Kritsotakis EI; Karageorgos SA; Stratakou S; Psarologakis C; Kokkini S; Gikas A
Int J Antimicrob Agents; 2016 Nov; 48(5):492-497. PubMed ID: 27542315
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for hospitalized patients with resistant or multidrug-resistant
Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of the clinical features and outcome of ventilator-associated Pseudomonas aeruginosa-related pneumonia in an intensive care unit].
Baĭgozina EA; Sovalkin VI; Lukach VN
Anesteziol Reanimatol; 2009; (2):62-4. PubMed ID: 19514444
[TBL] [Abstract][Full Text] [Related]
38. Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients.
Denis JB; Lehingue S; Pauly V; Cassir N; Gainnier M; Léone M; Daviet F; Coiffard B; Baron S; Guervilly C; Forel JM; Roch A; Papazian L
Am J Infect Control; 2019 Sep; 47(9):1059-1064. PubMed ID: 30962023
[TBL] [Abstract][Full Text] [Related]
39. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
[TBL] [Abstract][Full Text] [Related]
40. Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
Apisarnthanarak A; Mundy LM
Int J Antimicrob Agents; 2012 Mar; 39(3):271-2. PubMed ID: 22236455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
